RU58841: Research, Dosing, and Where to Buy in 2026
A research-first profile for RU58841 (RU 5841, RU), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
RU58841 is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 6 PubMed-cited papers, 9 attributed expert mentions, and 3 transcript dosing protocols for RU58841, each linked to its source.
- Also indexed as RU 5841, RU.
- 3 aggregated dosing-protocol mentions from source transcripts.
- 6 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
- Evidence level in this entry is marked as anecdotal.
What is RU58841?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Experts on background and overview · 5 cited mentions
"test a TRT dose topical dutestaster topical minoxidil topical RU 58841 um no other anabolics besides my minanderone"
"On my last cycle I started using RU 58841. And minoxidil. I think that stopped the progression of the hair loss."
"So I think the low-hanging fruit and the least invasive is probably minoxidil and RU if you're on cycle."
Show 2 more cited mentions on background and overview →
"minoxidil with dutasteride shampoo or 5 RU58841... topical androgen blocker"
"Topical RU, maybe you can minimize hair loss, but you cannot prevent it."
What is RU58841 researched for?
Topical anti-androgen for hair; high doses risk systemic anti-androgenic effects similar to spironolactone.
RU58841 Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Kurt | The ULTIMATE Hair Loss & Gyno Prevention Tier List (No Surgery Required) | 00:05:31 | Topical RU58841 used during cycle as anti-androgen alongside minoxidil; stop when off cycle (on TRT-only) | anecdotal |
| Devin | Saturday Morning Coffee Talk 6/6/26 | 01:47:20 | User reports RU58841 daily for male pattern baldness; Hunter says he likes those items. | anecdotal |
| Vigorous Steve | Best PED Use (Competitive vs. Lifestyle) & All Things to Avoid Death... | 01:57:58 | 5-10 mg/day topical to scalp (systemic risk at this dose) | anecdotal |
Where to Buy RU58841 in 2026
No tracked vendor recommendations for RU58841 yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
2 experts across our source library discuss RU58841. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“test a TRT dose topical dutestaster topical minoxidil topical RU 58841 um no other anabolics besides my minanderone”
-
“On my last cycle I started using RU 58841. And minoxidil. I think that stopped the progression of the hair loss.”
See 4 more expert mentions →
-
“So I think the low-hanging fruit and the least invasive is probably minoxidil and RU if you're on cycle.”
-
“minoxidil with dutasteride shampoo or 5 RU58841... topical androgen blocker”
-
“Topical RU, maybe you can minimize hair loss, but you cannot prevent it.”
-
“You need to run it quite high, right? Like 5 to 10 milligrams per day on top of your scalp. And then you risk it going systemic.”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about RU58841. Each line links to the original source.
- "Moreover, chiral alcohols such as ʟ-menthol are well tolerated, affording diastereomeric sulfinimidate esters that can undergo stereospecific Grignard substitutions to furnish enantioenriched sulfilimines with up to 93% ee." · Huang G et al, 2026 PubMed
- "The above three agents, 1% weight volume, were dissolved into the vehicle (propylene glycol, alcohol and water) and applied on the backs of peripubertal male rats for 2 months." · Ye F et al, 1997 PubMed
- "The results revealed that the sizes of both lobes and ducts in castrates were 40-60% smaller than in controls." · Ye F et al, 1997 PubMed
- "Each of the two equal groups of grafts was further allocated at random to be treated topically (5 days/week) with blinded solutions of either RU58841 1% in ethanol, or ethanol as a control." · De Brouwer B et al, 1997 PubMed
- "Among them only two follicles (7%) initiated a second hair cycle." · De Brouwer B et al, 1997 PubMed
- "However, the 10 RU58841-treated grafts bore a total of 29 active follicles, and eight of them (28%) showed a second cycle." · De Brouwer B et al, 1997 PubMed
- "I use 2% ketocon shampoo every other day." · Devin on "Saturday Morning Coffee Talk 6/6/26" @ 1:47:20
Research and Studies
6 PubMed-indexed papers reference RU58841. Top 6 shown.
Legal Status
RU58841 is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is RU58841 FDA-approved?
RU58841 is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for RU58841?
This page aggregates 3 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on RU58841?
6 PubMed-indexed paper(s) reference RU58841 in our current research feed. See the Research and Studies section above for citations.